Esperion Therapeutics, Inc. · NASDAQ:ESPR
Koenig Sheldon L. sold 53,588 Esperion Therapeutics, Inc. shares (Form 4)
Traded Jun 17, 2026 · Filed Jun 18, 2026
On Jun 17, 2026, Koenig Sheldon L. (Director, President and CEO) sold 53,588 Esperion Therapeutics, Inc. shares at US$3.16 for US$169K, leaving 2,119,111 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 53,588 shares
- Price
- US$3.16
- Value
- US$169K
- Holding after
- 2,119,111 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | Sale | 53,588 | US$3.16 | 2,119,111 | Direct |
Source
Related
- Esperion Therapeutics, Inc.
- Koenig Sheldon L.
- Esperion Therapeutics, Inc. shareholders
- Form 4 · Koenig Sheldon L. · Jul 13, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026